Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-070630
Filing Date
2006-03-31
Accepted
2006-03-31 16:03:58
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1010703
2 C.K. COOPER ENGAGEMENT LETTER dex1010.htm EX-10.10 28454
3 HOWARD HUGHES LEASE AGREEMENT dex1015.htm EX-10.15 284070
4 SUBLEASE AGREEMENT dex1017.htm EX-10.17 49007
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 1638
6 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 7066
7 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 7060
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex32.htm EX-32 7122
9 GRAPHIC g83621img_001.jpg GRAPHIC 102692
  Complete submission text file 0001193125-06-070630.txt   1538216
Mailing Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134
Business Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134 702-248-1174
CardioVascular BioTherapeutics, Inc. (Filer) CIK: 0001303497 (see all company filings)

EIN.: 330795984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51172 | Film No.: 06728966
SIC: 2834 Pharmaceutical Preparations